REG4 serves as a prognostic biomarker for pancreatic cancer with long-standing diabetes mellitus by modulating chemoresistance

Authors:

Abstract
No abstract available
Funding Information
  • Korea Health Industry Development Institute
  • Yonsei University College of Medicine
  • National Research Foundation of Korea

This publication has 36 references indexed in Scilit: